Clinical trial of a leucotriene B4 receptor antagonist, BIIL 284, in patients with rheumatoid arthritis
AUTOR(ES)
Díaz‐González, Federico
FONTE
BMJ Group
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1954613Documentos Relacionados
- Enhanced capacity for release of leucotriene B4 by neutrophils in rheumatoid arthritis.
- Effect of a leukotriene B4 receptor antagonist, LY293111, on allergen induced responses in asthma.
- Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients
- Clinical trial with a beta-receptor antagonist (propranolol) in parkinsonism.
- Interleukin-1 receptor antagonist production in cultured synovial cells from patients with rheumatoid arthritis and osteoarthritis.